FDA inspection

Summit Biosciences Inc.: FDA inspection ending Sep 14, 2023

FDA inspection 1218227 · No Action Indicated (NAI) · Lexington, KY

Key facts

Inspection ID 1218227
Firm Summit Biosciences Inc.
FEI number 3007577023
Address 1513 Bull Lea Rd
City Lexington
State KY
ZIP 40511
Country United States
Fiscal year 2023
Inspection end date Sep 14, 2023
Classification No Action Indicated (NAI)
Project area Compliance: Devices
Product type Devices

At a glance

  • None Citations
  • None Posted citations
  • No Warning letter followed
  • No Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections